SeaStar Medical (ICU)

• Market cap: $12.5M
• 1 day: -4.84%
• 5 days: -8.53%
• 1 month: -7.09%
• 3 months: -37.57%
• 6 months: -40.70%
• Year to date: -39.49%
• 1 year: -66.57%
• 5 years: -99.52%
• 10 years: -99.52%
• Sector: Healthcare
• Industry: Biotechnology

About: SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Employees: 19

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

326% more capital invested

Capital invested by funds: $351K [Q4 2024] → $1.5M (+$1.14M) [Q1 2025]

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

30% more funds holding

Funds holding: 20 [Q4 2024] → 26 (+6) [Q1 2025]

6.28% more ownership

Funds ownership: 4.07% [Q4 2024] → 10.35% (+6.28%) [Q1 2025]